Research

IP

Granted Patents -51
Last updated: 10/12/2019
Foreign - 32
Indian - 19
S.N. Country Title Patent no and date of grant Inventors
1. US Vaccine Composition Capable of Inducing Memory Antibody Response from Single Point Immunization US patent application 14/122,923
Issued on 30/7/2019
Chakkumkal A and Panda AK
2. EU Ig genes specific oligonucleotides and uses thereof. EP patent no. 2100970
Granted on 13/04/2017
Sehgal D and Rohatgi S
3. US Hemoglobin receptor as novel vaccine for leishmaniasis. US patent no. 9764015
Granted on 19/09/2017
Mukhopadhyay A, Roy S, Gupta D, Guha R and Rastogi R
4. US A recombinant vaccine against Clostridium Perfringens infection and Epsilon (έ) toxin intoxication US patent no. 9408900 
Granted on 09/08/2016
Garg LC, Dixit A and Keshav G
5. AU Recombinant non-toxic protein vaccine against Clostridium perfringens infection and epsilon toxin Intoxications Australian patent no. 2011275507
Granted on 14/07/2016
Garg LC, Dixit A and Keshav G
6. EP Recombinant non-toxic protein vaccine against Clostridium perfringens infection and epsilon toxin Intoxications EP patent no. 2591108
Granted on 11.03.2015
(Validated in UK)
Garg LC, Dixit A and Keshav G
7. EP RECQL4, the DNA helicase mutated in rothmund-thomson syndrome, regulated mithochondrial function EP patent no. 2398922
Granted on 29/04/2015
Validated in UK
Sengupta S
8. Australia Composition useful for treatment of diabetes & disorder Australian patent no. 2008354530
Granted on 26/06/2014
Avadhesha Surolia , Sarika Gupta, Mahendra Pal Singh , Tandrika Chattopadhyay
9. Canada Composition useful for treatment of diabetes & disorder Canadian patent no.
Granted on
Avadhesha Surolia , Sarika Gupta, Mahendra Pal Singh , Tandrika Chattopadhyay
10. Japan Composition useful for treatment of diabetes & disorder Japanese patent no.
Granted on
Avadhesha Surolia , Sarika Gupta, Mahendra Pal Singh , Tandrika Chattopadhyay
11. EP Composition useful for treatment of diabetes & disorder
(validated in Austria , Belgium, Croatia, Czech Republic, Finland, France, Greece, Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, United Kingdom
EP patent no: EP2133091
Granted on 19/04/2013
Avadhesha Surolia , Sarika Gupta, Mahendra Pal Singh, Tandrika Chattopadhyay
12. EP Process for preparing supramolecular calcitonin assemblies (SCA)
(Validated in UK and Germany)
EP patent no EP2282763
Granted on 24/10/2014
Avadhesha Surolia , Sarika Gupta, Mahendra Pal Singh , Tandrika Chattopadhyay
13. South Africa Composition useful for treatment of diabetes & disorder South African patent no
Granted on
Avadhesha Surolia , Sarika Gupta, Mahendra Pal Singh , Tandrika Chattopadhyay
14. US IG genes specific oligonucleotides and uses thereof US patent no. 8143007
Granted on 27/03/2012
Dr. Devinder Sehgal and Soma Rohtagi
15. Australia Process for obtaining bioactive recombinant protein from inclusion bodies Australian patent no. 2008249543
Granted on. 05/06/2014
AK Panda , Mohan Surinder Singh and Arun Kumar Updhayay
16. EP Process for obtaining bioactive recombinant protein from inclusion bodies)
(Validated in UK)
EP patent no. EP2147093
Granted on 31/05/2013
AK Panda -NII, Mohan Surinder Singh - NII and Arun Kumar Updhayay -- NII
17. US Novel Bioconjugates as therapeutic agent and Synthesis thereof. US patent no. 8148321
Granted on. 03/04/2012
R. P. Roy and Sharmishtha Samantaray
18. EP Polymer particle based vaccine
(Validated in UK)
EP patent no. 2139513
Granted on 29/10/2012
Dr. Amulya panda and Vibhu Kanchan
19. Australia Biodegradable polymer scaffold & process for preparation thereof Australian patent no. 2008315318
Granted on 24/05/2014
Dr. A. K. Panda , Rajmohan Gopimohan and CK Anish
20. EP Biodegradable polymer scaffold & process for preparation thereof
(Validated in UK)
EP patent no 2207577
Granted on 19/12/2014
Dr. A. K. Panda, Rajmohan Gopimohan and CK Anish
21. US Biodegradable polymer scaffold & process for preparation thereof US patent no 8268342 Granted on 18/09/2012 Dr. A. K. Panda , Rajmohan Gopimohan and CK Anish
22. South Africa Biodegradable polymer scaffold & process for preparation thereof SA patent no. 2010/03691
Granted on. 30/04/ 2012
Dr. A. K. Panda Rajmohan Gopimohan and CK Anish
23. US Inhibition of SPAG9 expression with SIRNAS US patent no. 8227591
Granted on 07/24/2012
Anil Suri
24. EP Inhibition of SPAG9 expression with SIRNAS
(Validated in Germany, France, UK, Finland, Italy, Sweden, Switzerland)
EP patent no: EP1861496
Granted on. 16/09/2009
Anil Suri
25. Australia Inhibition of SPAG9 expression with SIRNAS Australian patent no. 2006219666
Granted on 27/01/2011
Anil Suri
26. Singapore Inhibition of SPAG9 expression with SIRNAS SG patent no. 135339
Granted on 15/06/2010
Anil Suri
27. EP Novel Cancer Associated antibodies & antigens and their use in cancer diagnosis
(Validated ik UK)
EP patent no. 1796723
Granted on 12/10/2012
Anil Suri
28. Australia Novel Cancer Associated antibodies & antigens and their use in cancer diagnosis Australian patent no. 2005290997
Granted on 20/12/2012
Anil Suri
29. Singapore Novel Cancer Associated antibodies & antigens and their use in cancer diagnosis SG patent no. 156619
Granted on 13/07/2012   
Anil Suri
30. Australia Dnazymes for inhibition of Japanese encephalitis virus replication Australian patent no. 2005315143
Granted on 08/09/2011
S. Vrati and Mohan Babu Appaiahgari
31. Singapore Dnazymes for inhibition of Japanese encephalitis virus replication SG patent no. 133150
Granted on
Dr. S. Vrati and Mohan Babu Appaiahgari
32. USA Process for solubilisation of recombinant proteins expressed as inclusion body US patent no. 7189811
Granted on 03/03/2007
Dr. Amulya Kumar Panda , Sheikh Mohammed Gulebahar, Eshwari Addala Naga Sai, Lalit Chander Garg
 
Indian Patents – 19
1. India Recombinant nontoxic protein vaccine against Clostridium perfringens infection and epsilon toxin Intoxications. Indian patent no 319556
Granted on30/8/2019
Garg LC, Dixit A and Gopal K
2. India Monoclonal antibody specific to hemagglutinin from influenza virus h1-subtypeand uses thereof. Indian patent no 312710
Granted on 22/08/2019
Gupta SK, Shembekar N, Mishra A, Varadarajan R, Aditya VV, Subhash M, Kapre V, Yeolekar L, Dhere R
3. India Novel Bioconjugates as therapeutic agent and Synthesis thereof. Indian patent no  320958
Granted on 20 /09/2019
RP Roy and Sharmishtha Samantaray
4. India Novel Cancer Associated antibodies and their use in cancer diagnosis. Indian patent no 295616
Granted on 09/04/2018
Suri A
5. India Development of secretory expression and heterologous booster based DNA vaccine against ε-toxin of Clostridium perfringens Indian patent no. 309378
Granted on 18/03/2019
Deshmukh SK, Kaushik H, Sharma N, Mathur DD, Rupa P, Garg LC
6. India Novel immunotherapeutic method for treatment of cancer Indian patent no. 284087
Granted on 08/06/2017
Suri A
7. India Immunotherapeutic Composition Indian patent no. 286707
Granted on 28/08/2017
Suri A
8. India Spray dried formulation of antigen containing alum or antigen entrapped polymer particles with surface coated of alum. Indian patent no 288726 
Granted on 25/10/2017
Panda AK , Anish CK and Goswami DG
9. India A vaccine composition comprising polymeric nanoparticles and microparticles for inducing TH1 and TH2 response Indian patent no. IN278769
Granted on 30/12/2016
Panda AK, Kanchan V Polymer particles based vaccine
10. India Immunoglobulin genes specific oligonucleotides and uses thereof. Indian patent no. 280165
Granted on 13/02/2017
Sehgal D and Rohatgi S
11. India Process for obtaining bioactive recombinant protein from inclusion bodies Indian patent no 267617
Granted on 27/07/2015
Panda AK, Singh MS and Updhayay AK
12. India siRNA useful in inhibiting cellular growth/proliferation of cancerous tissues Indian patent no 257434
Granted 01/10/2013
Anil Suri
13. India Recombinant vaccine against Japanese encephalitis virus (JEV) infection and method thereof Indian patent no 243547
Granted on 25/10/2010
S. Vrati
14. India A process for solubilization and recovery of bioactive proteins from host cells Indian patent no 217145
Granted on 27/03/2008
Dr. Amulya Kumar Panda , Sheikh Mohammed Gulebahar, Eshwari Addala Naga Sai, Lalit Chander Garg
15. India A process for the preparation of pharmaceutical grade plasmid DNA for therapeutic application. Indian patent no 246388
Granted 9/02/2011
Panda AK
16. India A vaccine for the development of immunological memory Indian patent no 231109
Granted 03/03/2009
Panda AK and Katare YK
17. India A process for the preparation of a vaccine for the developing immunological from single dose Indian patent no 217115
Granted on 25/3/2008
Panda AK and Katare YK
18. India A Process for improving the immunogenicity of a weak antigen Indian patent no Granted 220690
Granted on 02/06/ 2008
Panda AK, Venkatesan N, Singh O and Pal R
19. India Process for the formulation of a single dose vaccine Indian patent no 199589
Granted on 27/09/2007
Panda AK

Copyright © 2012 National Institute of Immunology. All Rights Reserved.

150 Years of Celebrating The Mahatma